Brought to you by 
Inventiva Pharma closes €42.7mm initial public offering
13 Sep 2017
Executive Summary
Inventiva Pharma (developing treatments for fibrosis and rare/orphan diseases) netted €42.7mm ($45mm) through its initial public offering on Compartment C of Euronext. The company sold 5.65mm new shares at €8.50.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inventiva Pharma closes €42.7mm initial public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice